Merestinib In Non-Small Cell Lung Cancer And Solid Tumors

NCT02920996 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

12

Enrollment

OTHER

Sponsor class

Stopped Funding was pulled

Conditions

Carcinoma, Non-Small-Cell Lung
Solid Tumor

Interventions

DRUG: Merestinib

Sponsor

Dana-Farber Cancer Institute

Collaborators

[object Object]